Delivery Order SPE2DB24D3013-SPE2DB25FFPCA
- Not listed
- The Defense Logistics Agency awarded a $8,617.81 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zileuton ER 600 mg tablets (120 count). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of July 28, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $46,601.78 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Zyflo 600 mg on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $10,285.72 to AmerisourceBergen Drug Corp for the supply of Zyflo 600 mg tablets (120-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract utilizes firm fixed price terms with no set-aside designation, reflecting open and competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lazicluze 240 mg tablets (30-count units) with a ceiling value of $12,446.16. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, represents a non-competitive set-aside transaction executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $2,963.45. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,219.54. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,496.63 on July 28, 2025, with a completion date of July 29, 2025. This non-set-aside contract procures VEOZAH 45 mg tablets in a 30-count package under a firm fixed-price arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Linezolid 600 mg tablets in quantities of 20 units. This order, valued at $1,129.06 with a firm fixed price structure, represents a non-competed delivery against an existing contract vehicle and is scheduled for completion by August 26, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count) with a ceiling value of $2,218.14. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by July 28, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,046.46 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (a combination respiratory medication), with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFPCADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zileuton ER 600 mg tablets (120 count) with a ceiling value of $4,620.21. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by August 7, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of medications and medical supplies to support military healthcare systems and the Defense Health Agency. Zileuton ER, a leukotriene inhibitor used for asthma management, represents one of the specialized pharmaceutical products the company delivers under this global pharmaceutical support vehicle to sustain military medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/6/25 |